Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

Treatment options for neuroendocrine tumors (NETs) and carcinomas (NECs) are expanding. Early-phase studies have shown preliminary evidence of the antitumor activity of alpha-emitting peptide receptor radionuclide therapy (PRRT), and novel radiopeptides incorporating somatostatin receptor antagonist...

Descripción completa

Detalles Bibliográficos
Autores principales: Cives, Mauro, Pelle’, Eleonora, Strosberg, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696369/
https://www.ncbi.nlm.nih.gov/pubmed/33202931
http://dx.doi.org/10.3390/jcm9113655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696369/
https://www.ncbi.nlm.nih.gov/pubmed/33202931
http://dx.doi.org/10.3390/jcm9113655

Ejemplares similares